Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis
The authors declare no conflicts of interest. The data supporting this study's findings are available from the corresponding author upon reasonable request.
Authors
- Jun‐Ting Tang (ORCID: https://orcid.org/0000-0002-0530-4703)
- Nanhui Wu (ORCID: https://orcid.org/0000-0002-2006-2220)
- Ming Xu
- Fei Wu (ORCID: https://orcid.org/0000-0003-3140-6954)
- Ye Qiang Liu
Institutions
- Tongji University (CN)
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Shanghai Skin Disease Hospital (CN)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1111/ijd.17742
- Citations
- 4
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 3.19
Funders
- National Natural Science Foundation of China